Metotrexato Wyeth

Methotrexate, the active ingredient in Metotrexato Wyeth, is an Antimetabolite (Folate antagonist) presented as a sterile solution for intramuscular, intrathecal and intravenous use. It is employed to treat autoimmune disorders, certain cancers and ectopic pregnancy in adult patients. GNH USA supplies Metotrexato Wyeth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexate is used across several disease families, primarily as an antimetabolite that interferes with rapidly dividing cells and immune pathways. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: diminishes skin plaque formation and severity. - Acute lymphoblastic leukemia: induces remission by targeting malignant lymphoblasts. - Non‑Hodgkin lymphoma: contributes to tumor control as part of combination chemotherapy. - Breast cancer: used in high‑dose regimens for certain hormone‑receptor‑negative tumors. - Ectopic pregnancy: medically terminates early tubal implantation.

Methotrexate can cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting. - Fatigue or malaise. - Mouth sores or ulceration. - Mild elevation of liver enzymes. - Transient low white blood cell count. - Skin rash or itching.

Serious or Rare Side Effects: - Severe liver toxicity or fibrosis. - Pulmonary fibrosis or severe pneumonitis. - Bone marrow failure leading to pancytopenia. - Acute renal failure. - Life‑threatening infection due to immunosuppression. - Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, clinicians should assess baseline organ function and counsel patients on potential risks. - Liver monitoring: perform regular liver function tests and avoid concurrent hepatotoxic drugs. - Hematologic monitoring: check complete blood counts frequently to detect cytopenias. - Pregnancy avoidance: contraindicated in pregnancy; ensure effective contraception for both sexes. - Renal dose adjustment: modify dose in patients with impaired renal function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexate interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Proton pump inhibitors (e.g., omeprazole): may raise serum levels. - Trimethoprim‑sulfamethoxazole: enhances myelosuppression. - Live vaccines: risk of severe infection. - High‑dose aspirin: potentiates toxicity.

Moderate Interactions (Monitor Closely): - Azathioprine or other immunosuppressants: additive bone‑marrow suppression. - Sulfonamide antibiotics: may increase adverse effects. - Carbamazepine: may reduce methotrexate efficacy. - Phenytoin: can alter methotrexate metabolism. - Vitamin B12 supplements: may affect folate pathways.